|
1
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Badgwell B: Multimodality therapy of
localized gastric adenocarcinoma. J Natl Compr Canc Netw.
14:1321–1327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fang M, Wu J, Lai X, Ai H, Tao Y, Zhu B
and Huang L: CD44 and CD44v6 are correlated with gastric cancer
progression and poor patient prognosis: Evidence from 42 studies.
Cell Physiol Biochem. 40:567–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Fei X, Wu W, Chen X, Su L, Zhu Z
and Zhou Y: SLC7A5 Functions as a Downstream Target Modulated by
CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells. PLoS
One. 11:e01661472016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lawrence W. Way and Gerard M. Doherty:
Current surgical diagnosis & treatment. 11th. McGraw-Hill
Companies, Inc.; New York: pp. 285–287. 2003
|
|
6
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2001.
|
|
7
|
Kim HY, Cho Y, Kang H, Yim YS, Kim SJ,
Song J and Chun KH: Targeting the WEE1 kinase as a molecular
targeted therapy for gastric cancer. Oncotarget. 7:49902–49916.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th. Springer; New
York: pp. 93–99. 2017
|
|
9
|
Roder JD, Böttcher K, Busch R, Wittekind
C, Hermanek P and Siewert JR: Classification of regional lymph node
metastasis from gastric carcinoma. German Gastric Cancer Study
Group. Cancer. 82:621–631. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim DH, Kim HS, Park YS, Lee J, Park SH,
Lim HY, Ji SH, Park MJ, Yi SY, An JY, et al: Metastatic lymph node
in gastric cancer; is it a real distant metastasis? BMC Cancer.
10:252010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akagi T, Shiraishi N and Kitano S: Lymph
Node Metastasis of Gastric Cancer. Cancers (Basel). 3:2141–2159.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JJ and Xie D: RACK1, a versatile hub in
cancer. Oncogene. 34:1890–1898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gandin V, Senft D, Topisirovic I and Ronai
ZA: RACK1 function in cell motility and protein synthesis. Genes
Cancer. 4:369–377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gibson TJ: RACK1 research-ships passing in
the night? FEBS Lett. 586:2787–2789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robles MS, Boyault C, Knutti D,
Padmanabhan K and Weitz CJ: Identification of RACK1 and protein
kinase Calpha as integral components of the mammalian circadian
clock. Science. 327:463–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bird RJ, Baillie GS and Yarwood SJ:
Interaction with receptor for activated C-kinase 1 (RACK1)
sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP
and activation by protein kinase C. Biochem J. 432:207–216. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang W, Zong CS, Hermanto U,
Lopez-Bergami P, Ronai Z and Wang LH: RACK1 recruits STAT3
specifically to insulin and insulin-like growth factor 1 receptors
for activation, which is important for regulating
anchorage-independent growth. Mol Cell Biol. 26:413–424. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haberman Y, Alon LT, Eliyahu E and Shalgi
R: Receptor for activated C kinase (RACK) and protein kinase C
(PKC) in egg activation. Theriogenology. 75:80–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Liu Y, Jin F, Sun X, Li Z, Liu Y,
Fang P, Shi H and Jiang X: Endothelin-1 induces hypoxia inducible
factor 1α expression in pulmonary artery smooth muscle cells. FEBS
Lett. 586:3888–3893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu M, Peng P, Wang J, Wang L, Duan F, Jia
D, Ruan Y and Gu J: RACK1-mediated translation control promotes
liver fibrogenesis. Biochem Biophys Res Commun. 463:255–261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng D, Zhu X, Barchiesi F, Gillespie DG,
Dubey RK and Jackson EK: Receptor for activated protein kinase C1
regulates cell proliferation by modulating calcium signaling.
Hypertension. 58:689–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su J, Xu J and Zhang S: RACK1, scaffolding
a heterotrimeric G protein and a MAPK cascade. Trends Plant Sci.
20:405–407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia X, Zhang L and Mao X: S-propranolol
protected H9C2 cells from ischemia/reperfusion-induced apoptosis
via downregultion of RACK1 Gene. Int J Clin Exp Patho.
l8:10335–10344. 2015.
|
|
24
|
Grosso S, Volta V, Sala LA, Vietri M,
Marchisio PC, Ron D and Biffo S: PKCbetaII modulates translation
independently from mTOR and through RACK1. Biochem J. 415:77–85.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang
W, Xie J, Guo L, Zhou L, Yun X, et al: Ribosomal RACK1 promotes
chemoresistance and growth in human hepatocellular carcinoma. J
Clin Invest. 122:2554–2566. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Campagne C, Julé S, Alleaume C, Bernex F,
Ezagal J, Château-Joubert S, Estrada M, Aubin-Houzelstein G,
Panthier JJ and Egidy G: Canine melanoma diagnosis: RACK1 as a
potential biological marker. Vet Pathol. 50:1083–1090. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li
QQ, Chen Q, Xu ZD and Liu XP: RACK1: A superior independent
predictor for poor clinical outcome in breast cancer. Int J Cancer.
127:1172–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Cui M, Teng H, Wang F, Yu W and Xu
T: Silencing the receptor of activated C-kinase 1 (RACK1)
suppresses tumorigenicity in epithelial ovarian cancer in vitro
in vivo. Int J Oncol. 44:1252–1258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi YY, Lee SY, Lee WK, Jeon HS, Lee EB,
Lee HC, Choi JE, Kang HG, Lee EJ, Bae EY, et al: RACK1 is a
candidate gene associated with the prognosis of patients with early
stage non-small cell lung cancer. Oncotarget. 6:4451–4466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Liu N, Ma D, Liu L, Jiang L, Zhou
Y, Zeng X, Li J and Chen Q: Receptor for activated C kinase 1
(RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Int J Oncol. 49:539–548. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Ke Q, Li Y, Liu F, Zhu G and Li F:
DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated
migration of human gastric cancer cell via LIMK1. Int J Biochem
Cell Biol. 42:70–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long
LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric
tumorigenesis by stabilizing the β-catenin destruction complex.
Gastroenterology. 142:812–823.e15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen L, Min L, Wang X, Zhao J, Chen H, Qin
J, Chen W, Shen Z, Tang Z, Gan Q, et al: Loss of RACK1 promotes
metastasis of gastric cancer by inducing a miR-302c/IL8 signaling
loop. Cancer Res. 75:3832–4381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yong-Zheng X, Wan-Li M, Ji-Ming M and
Xue-Qun R: Receptor for activated protein kinase C 1 suppresses
gastric tumor progression through nuclear factor-kB pathway. Indian
J Cancer. 52 Suppl 3:E172–E175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Núñez A, Franco A, Soto T, Vicente J,
Gacto M and Cansado J: Fission yeast receptor of activated C kinase
(RACK1) ortholog Cpc2 regulates mitotic commitment through Wee1
kinase. J Biol Chem. 285:41366–41373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang F, Osawa T, Tsuchida R, Yuasa Y and
Shibuya M: Downregulation of receptor for activated C-kinase 1
(RACK1) suppresses tumor growth by inhibiting tumor cell
proliferation and tumor-associated angiogenesis. Cancer Sci.
102:2007–2013. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mueller S, Hashizume R, Yang X, Kolkowitz
I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, et
al: Targeting Wee1 for the treatment of pediatric high-grade
gliomas. Neuro Oncol. 16:352–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Magnussen GI, Holm R, Emilsen E, Rosnes
AK, Slipicevic A and Flørenes VA: High expression of wee1 is
associated with poor disease-free survival in malignant melanoma:
Potential for targeted therapy. PLoS One. 7:e382542012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kreahling JM, Foroutan P, Reed D, Martinez
G, Razabdouski T, Bui MM, Raghavan M, Letson D, Gillies RJ and
Altiok S: Wee1 inhibition by MK-1775 leads to tumor inhibition and
enhances efficacy of gemcitabine in human sarcomas. PLoS One.
8:e575232013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Murrow LM, Garimella SV, Jones TL, Caplen
NJ and Lipkowitz S: Identification of WEE1 as a potential molecular
target in cancer cells by RNAi screening of the human tyrosine
kinome. Breast Cancer Res Treat. 122:347–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
